245 related articles for article (PubMed ID: 33478193)
21. Tumor Mutation Burden and Checkpoint Immunotherapy Markers in NUT Midline Carcinoma.
He M; Chernock R; Zhou S; Gondim M; Dehner LP; Pfeifer JD
Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):495-500. PubMed ID: 31180909
[TBL] [Abstract][Full Text] [Related]
22. NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.
Agaimy A; Fonseca I; Martins C; Thway K; Barrette R; Harrington KJ; Hartmann A; French CA; Fisher C
Am J Surg Pathol; 2018 Jul; 42(7):877-884. PubMed ID: 29649019
[TBL] [Abstract][Full Text] [Related]
23. NUT Carcinoma in a Patient with Unusually Long Survival and False Negative FISH Results.
McLean-Holden AC; Moore SA; Gagan J; French CA; Sher D; Truelson JM; Bishop JA
Head Neck Pathol; 2021 Jun; 15(2):698-703. PubMed ID: 32918711
[TBL] [Abstract][Full Text] [Related]
24. NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primary.
Shehata BM; Steelman CK; Abramowsky CR; Olson TA; French CA; Saxe DF; Ricketts RR; Katzenstein HM
Pediatr Dev Pathol; 2010; 13(6):481-5. PubMed ID: 20017639
[TBL] [Abstract][Full Text] [Related]
25. Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases.
Giridhar P; Mallick S; Kashyap L; Rath GK
Eur Arch Otorhinolaryngol; 2018 Mar; 275(3):815-821. PubMed ID: 29356890
[TBL] [Abstract][Full Text] [Related]
26. Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.
Agaimy A; Haller F; Renner A; Niedermeyer J; Hartmann A; French CA
Am J Surg Pathol; 2022 Feb; 46(2):281-288. PubMed ID: 34232599
[TBL] [Abstract][Full Text] [Related]
27. Primary pulmonary NUT midline carcinoma: An elusive and a rare diagnostic entity.
Pasricha S; Jajodia A; Sharma A; Bansal D; Batra U; Gupta G; Durga G; Kamboj M; Nathany S; Mehta A
J Cancer Res Ther; 2023; 19(3):816-818. PubMed ID: 37470617
[TBL] [Abstract][Full Text] [Related]
28. NUT carcinoma presenting in the palate - a case report.
Bjornstrup LR; Reibel J; Kiss K; Schioedt M
APMIS; 2017 Oct; 125(10):933-936. PubMed ID: 28544145
[TBL] [Abstract][Full Text] [Related]
29. Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.
Sholl LM; Nishino M; Pokharel S; Mino-Kenudson M; French CA; Janne PA; Lathan C
J Thorac Oncol; 2015 Jun; 10(6):951-9. PubMed ID: 26001144
[TBL] [Abstract][Full Text] [Related]
30. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.
Engleson J; Soller M; Panagopoulos I; Dahlén A; Dictor M; Jerkeman M
BMC Cancer; 2006 Mar; 6():69. PubMed ID: 16542442
[TBL] [Abstract][Full Text] [Related]
31. Salivary Gland NUT Carcinoma with Prolonged Survival in Children: Case Illustration and Systematic Review of Literature.
Wang H; Weiss VL; Hoffman RD; Abel T; Ho RH; Borinstein SC; Mannion K; Bridge JA; Black J; Liang J
Head Neck Pathol; 2021 Mar; 15(1):236-243. PubMed ID: 32077054
[TBL] [Abstract][Full Text] [Related]
32. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
Chen M; Chen X; Zhang Y; Wang W; Jiang L
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907
[TBL] [Abstract][Full Text] [Related]
33. Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations.
Fekkar A; Emprou C; Lefebvre C; Ferretti G; Stephanov O; Pissaloux D; Mc Leer A; Toffart AC; Rousseaux S; Khochbin S; Lantuejoul S; Valmary-Degano S
Lung Cancer; 2021 Aug; 158():55-59. PubMed ID: 34119933
[TBL] [Abstract][Full Text] [Related]
34. NUT midline carcinoma of the parotid gland with mesenchymal differentiation.
den Bakker MA; Beverloo BH; van den Heuvel-Eibrink MM; Meeuwis CA; Tan LM; Johnson LA; French CA; van Leenders GJ
Am J Surg Pathol; 2009 Aug; 33(8):1253-8. PubMed ID: 19561446
[TBL] [Abstract][Full Text] [Related]
35. NUT carcinoma - An aggressive thoracic tumor.
Ribeiro JA; Sousa J; Jesus F; Almeida É; Costa JF; Reis M; Gomes RM
Am J Med Sci; 2023 Jul; 366(1):64-70. PubMed ID: 37100347
[TBL] [Abstract][Full Text] [Related]
36. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
[TBL] [Abstract][Full Text] [Related]
37. Nuclear protein in testis midline carcinomas: a lethal and underrecognized entity.
Davis BN; Karabakhtsian RG; Pettigrew AL; Arnold SM; French CA; Brill YM
Arch Pathol Lab Med; 2011 Nov; 135(11):1494-8. PubMed ID: 22032580
[TBL] [Abstract][Full Text] [Related]
38. NUT carcinoma in children and adults: A multicenter retrospective study.
Lemelle L; Pierron G; Fréneaux P; Huybrechts S; Spiegel A; Plantaz D; Julieron M; Dumoucel S; Italiano A; Millot F; Le Tourneau C; Leverger G; Chastagner P; Carton M; Orbach D
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643357
[TBL] [Abstract][Full Text] [Related]
39. First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation.
Vulsteke C; Lurquin E; Debiec-Rychter M; Gheysens O; Nuyts S; Schoenaers J; Politis C; Mebis J; Hauben E; Clement PM
J Chemother; 2016 Jun; 28(3):242-6. PubMed ID: 26027633
[TBL] [Abstract][Full Text] [Related]
40. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
